The following articles from
Vol.5 No.4 Spring 2009
are available to Section members.
Click here to access by Topic Index.
Current Issue
Mesage from the Chair: Where Were You in 1974?
The third column from this year’s Chair of the Section of Science & TechnologyLaw.
By Ruth Hill Bro
Clinical Trials and the Financial Markets
Recently, physician-researchers have developed financial relationships with the investment
industry. Although cooperative agreements between research-based pharmaceutical
or biotechnology companies and physician-researchers have fostered a number of advances
in medical treatments, the impact of the relationships between researchers and investment
firms on the progress of medicine is not so clear.
By Mark S. Frankel, Ph.D.
Patents in the Croshairs
The European Commission has recently made a controversial inquiry into competition in the pharmaceuticals sector. The interim findings are troubling. Rather than focusing on promoting improvements to Europe’s byzantine regulatory landscape for pharmaceuticals, the report appears to characterize as suspect a range of practices relating to patents, patent litigation,
settlements, and marketing of next-generation technologies that most had previously regarded as being business as usual in high-tech industries. The pharmaceutical inquiry may have far broader implications for other IP-driven sectors.
By Bill Batchelor
The TGN1412 Drug Disaster
In 2006, six volunteers were seriously injured while taking part in a Phase I clinical trial for TGN1412, a new and promising compound being developed by TeGenero Immuno Therapeutics. Unfortunately, the TGN1412 study was not an isolated incident. Some irregularities identified in the TGN1412 trial procedure may be reflected in other trials. This article examines regulatory ways to improve the clinical trial process.
By P.R. Ferguson
Imagine the Ram-if-ications : Assesing Liability for Robotics -Based
Car Accidents
No real-world collision between robotic cars has occurred yet. Accordingly, no court has
considered how liability would be determined. However, it is clear that the day a court
must assess liability for robotic driving mistakes is fast approaching. How a court will look
at a tort caused by a robotic car is an exercise in prediction. But by looking at the history of
other “self-driven devices,” it is possible to imagine the factors that a court might consider.
By K. Krasnow Waterman and Matthew T. Henshon
EDDE Comite
Find out what’s going on in this vital Section committee.
By Eleanor Kellett and Steven Teppler
Resources for Student Members
Find out how students can get the most of their Section memberships.
By Mitch Tobias
CPO Corner: Lyn Goldstein
An interview with the chief privacy officer of JPMorgan Chase.
By Ruth Hill Bro
B-Tech Update
In this quarterly column, find coverage of biotech schools, stem cells, and GM crops.
By Calhoun “Reb” Thomas III
E-Tech Update
In this quarterly column, find coverage of patent reform and website subscriptions.
By Robert Bauer
SciTech Profiles: Wiliam Ludy
A profile of Section Council Member William Luddy.
By Clara Cottrell
|
|
Major Stories
|
Spring 2009:
CLINICAL TRIALS
|
|
Winter 2009:
BIOSECURITY
|
|
Fall 2008:
DIGITAL SECURITY
PRIVACY
|
|
Summer 2008:
FRONTIERS IN DIGITAL SECURITY
|
View The SciTech Lawyer Fall 2006.
|
